期刊文献+

骨肉瘤PTEN启动子特定区域甲基化的研究 被引量:3

Methylation of PTEN promoter specific domain in osteosarcoma
原文传递
导出
摘要 目的:检测骨肉瘤组织中人第10号染色体缺失的磷酸酶及张力蛋白同源的基因(PTEN)启动子特定区域的甲基化状态,初步探索PTEN在骨肉瘤发生、发展中的作用。方法:应用基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)方法,检测并分析32例骨肉瘤患者的病理组织中及17名正常对照者的外周血中抑癌基因PTEN启动子003区域CpG岛的甲基化状态。结果:骨肉瘤好发于股骨远端(20.9%)、胫骨近端(20.9%)和肱骨远端(16.3%)。骨肉瘤组织中抑癌基因PTEN启动子003区域CpG_1、CpG_3.4、CpG_9、CpG_11.12,CpG_13和CpG_18.19.20的甲基化率高于其在正常人外周血样中的甲基化率(P<0.05)。结论:PTEN基因启动子高甲基化导致的PTEN基因失活可能参与了骨肉瘤的发生、发展。 Objective To investigate the promoter CpG islands methylation status of tumor suppressor gene PTEN in osteosarcoma and to investigate the function of PTEN in the pathogenesis of osteosarcoma. Methods Forty-three cases of osteosarcoma were collected. The CpG islands methylation ratio of PTEN promoter 003 domain were detected by MALDI- TOF MS in 32 cases of osteosarcoma and blood samples of 17 normal individuals. Results Forty-three cases of osteosarcoma comprised 20 male (46.5%) and 23 female (53.5%); male to female ratio was 1:1.15. The ages of patients ranged from 9-74 years, with a median age of 25 and mean age of 30. 20.9% of the osteosarcoma were located in the distal femur, 20,9% in the proximal tibia and 16.3% in distal humerus. The methylatiou ratio of CpG_1, CpG_3.4, CpG9, CpG_I 1.12,CpG_13 and CPG_18.19.20 in PTEN promoter 003 domain was significantly higher than that of normal blood sample control (P〈0.05). Conclusions High methylation ratio of PTEN promoter may cause the loss of PTEN function and be involved in the pathogenesis of osteosarcoma.
出处 《诊断学理论与实践》 2013年第1期86-89,共4页 Journal of Diagnostics Concepts & Practice
基金 国家自然科学基金-西部项目(30560169)
关键词 骨肉瘤 人第10号染色体缺失的磷酸酶及张力蛋白同源的基因 抑癌基因 甲基化 Osteosarcoma PTEN Tumor suppressor gene Methylation
  • 相关文献

参考文献15

  • 1Arndt CA, Rose PS, Folpe AL, et al. Common musculoskeletal tumors of childhood and adolescence[J]. Mayo Clin Proc, 2012,87(5):475-487.
  • 2葛相栓,吴正祥.抑癌基因PTEN在肿瘤发生发展中的作用[J].安徽医药,2007,11(11):963-964. 被引量:5
  • 3Freeman SS, Allen SW, Ganti R, et al. Copy number gains in EGFR and copy number losses in ['TEN are common events in osteosarcoma tumors [J]. Cancer,2008, 113(6):1453-1461.
  • 4Levine RA, Forest T, Smith C. Tumor suppressor PTEN is mutated in canine osteosarcoma cell lines and tumors [J]. Vet Pathol, 2002,39(3):372-378.
  • 5Cui J, Wang W, Li Z, et al. Epigenetic changes in osteosarcoma[J]. Bull Cancer, 2011,98(7):E62-E68.
  • 6Yin L, Liu CX, Nong WX, et al. Mutational analysis of p53 and PTEN in soft tissue sarcoma[J]. Mol Med Report, 2012,5(2):457-461.
  • 7赵志敏,刘东,王巍伟,李锋,潘晓琳.新疆哈萨克族食管鳞癌miR-34a基因甲基化改变及其意义[J].农垦医学,2011,33(5):385-389. 被引量:1
  • 8Yim EK, Peng G, Dai H, et al. Rak functions as a tumor suppressor by regulating PTEN protein stability and functionfJ]. Cancer Ce11,2009,15(4):304-314.
  • 9黄涛,孙洁,吕刚,李建华,高大新,杨茂伟,王岩峰.PTEN在骨肉瘤组织中的表达及意义[J].中国医科大学学报,2004,33(3):245-246. 被引量:2
  • 10Mulholland D J, Tran LM, Li Y, et al. Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth[J]. Cancer Cell, 2011,19(6):792-804.

二级参考文献91

共引文献27

同被引文献40

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部